BusinessMedical DevicesNewsTechnology

2B BlackBio is Focused on Reducing Mortality Rates with Early Sepsis Detection Kit

1 Mins read

2B BlackBio is a privately held company based in Madrid, Spain focused on becoming a leader in personalized medicine and diagnostics.

2B BlackBio is a privately held company based in Madrid, Spain focused on becoming a leader in personalized medicine and diagnostics. Founded in 2009, the company has recently completed a round of funding through the Madrid Network and the Spanish Ministry of Science and Innovation. The 2 million euros in funding will support the continued development and validation BlackBio’s proprietary “accelerated high-sensitivity microsequencing patent.”

A recent product of note is the BlackLight® Sepsis Kit, which is currently under clinical evaluation. The sepsis detection kit has been extensively tested on real hospital samples, which have led to recognition of both common and rarer pathogens. Sepsis is a condition that occurs when there is a system inflammatory response to a microbial infection. According to the Sepsis Alliance (a charitable organization dedicated to combating sepsis), American hospitals spend approximately $20 billion each year combating the deadly condition, which is often linked to infections such as appendicitis or pneumonia. Currently, about 40 percent of patients diagnosed with a serious case of sepsis do not survive. Nearly 1,400 people worldwide die each day from this toxic condition.

According to BlackBio, the increased sepsis rates can be attributed to an increase in organ transplants and other surgeries that require suppression of the immune system. Additionally, a growing elderly population and the overuse of antibiotics has created drug-resistant bacteria are other reasons for the increase in sepsis.

Early detection is considered the best chance for sepsis survival, and BlackBio seeks to help increase this early detection with their early detection kit.

How It Works

With a minimal sample size and diagnosis completed in less than four hours, the cost-competitive, easy-to-use kit is designed to identify the species of bacteria by generating sequences covering three regions of the 16S ribosomal DNA. When these sequences are compared with the kit’s included database, the microorganism causing the infection can be identified in a timely manner. This early detection could reduce sepsis death by half proper treatment is administered within 48 hours.

To learn more about BlackBio’s BlackLight Sepsis detection kit and their other technologies, please visit www.blackbio.eu. BlackBio presented its products and technologies at OneMedForumSF January 9-12.

 

Related posts
News

Health Benefits of Cabin Beds with Desks for Home School Kids in Lockdown?

3 Mins read
A lot more children are doing homeschooling than ever before. Around 65% of households have reported that children are using remote learning….
BusinessHospital Administration

4 Ways to Enhance Clinical Documentation to Resolve Headaches as a Provider

2 Mins read
In the healthcare sector, information is vital to improving clinical outcomes and saving lives. This is the reason why institutions are always…
DiagnosticsTechnology

New Medical Laboratories Are the Key to Diagnostics Research

3 Mins read
The development of the COVID-19 vaccine was a miracle in medical research. It shows the incredible importance of medical innovation in the…